User profiles for Patrik Brundin
Patrik BrundinHoffmann-La Roche AG Verified email at roche.com Cited by 63570 |
Parkinson disease
…, K Seppi, CM Tanner, GM Halliday, P Brundin… - Nature reviews Disease …, 2017 - nature.com
Parkinson disease is the second-most common neurodegenerative disorder that affects 2–3%
of the population≥ 65 years of age. Neuronal loss in the substantia nigra, which causes …
of the population≥ 65 years of age. Neuronal loss in the substantia nigra, which causes …
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Two subjects with Parkinson's disease who had long-term survival of transplanted fetal
mesencephalic dopaminergic neurons (11–16 years) developed α-synuclein–positive Lewy …
mesencephalic dopaminergic neurons (11–16 years) developed α-synuclein–positive Lewy …
Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein
J Lotharius, P Brundin - Nature Reviews Neuroscience, 2002 - nature.com
Parkinson's disease is a devastating neurological condition that affects at least four million
people. A striking feature of this disorder is the preferential loss of dopamine-producing …
people. A striking feature of this disorder is the preferential loss of dopamine-producing …
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
…, P Kallunki, K Fog, JY Li, P Brundin - The Journal of …, 2011 - Am Soc Clin Investig
… Jia-Yi Li and Patrik Brundin are co–senior authors. … Jia-Yi Li and Patrik Brundin are co–senior
authors. … Jia-Yi Li and Patrik Brundin are co–senior authors. …
authors. … Jia-Yi Li and Patrik Brundin are co–senior authors. …
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
Neural transplantation can restore striatal dopaminergic neurotransmission in animal models
of Parkinson's disease. It has now been shown that mesencephalic dopamine neurons, …
of Parkinson's disease. It has now been shown that mesencephalic dopamine neurons, …
[PDF][PDF] The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg
A Ciechanover, P Brundin - Neuron, 2003 - cell.com
The ubiquitin-proteasome system targets numerous cellular proteins for degradation. In
addition, modifications by ubiquitin-like proteins as well as proteins containing ubiquitin-…
addition, modifications by ubiquitin-like proteins as well as proteins containing ubiquitin-…
Prion-like transmission of protein aggregates in neurodegenerative diseases
Neurodegenerative diseases are commonly associated with the accumulation of intracellular
or extracellular protein aggregates. Recent studies suggest that these aggregates are …
or extracellular protein aggregates. Recent studies suggest that these aggregates are …
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
Synaptic dopamine release from embryonic nigral transplants has been monitored in the
striatum of a patient with Parkinson's disease using [11 C]-raclopride positron emission …
striatum of a patient with Parkinson's disease using [11 C]-raclopride positron emission …
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
…, A Khalili-Shirazi, MW Lowdell, P Brundin… - The Journal of …, 2008 - rupress.org
Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by both
neurological and systemic abnormalities. We examined the peripheral immune system and …
neurological and systemic abnormalities. We examined the peripheral immune system and …